Trial Profile
Phase I study evaluating the safety, tolerability and maximally tolerated dose of L-000021649 administered in multiple doses
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Jan 2006
Price :
$35
*
At a glance
- Drugs L 21649 (Primary)
- Indications Acute myeloid leukaemia; Solid tumours
- Focus Adverse reactions
- 27 Jan 2006 New trial record.